HemoShear Therapeutics

0 followers

HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.


Org chart

Paul Sartori
VP - Organization Development and HR
Ryan Feaver
Executive Director, Head Of Exploratory Biology
Mark Hayes
Acting Chief Regulatory Officer

Board & advisors

John L. Brooks III
Board Member
John Tilton
Board Member
Gerald Cox
Advisor
Tom Roper
Advisor